Exploring the effects of methylenetetrahydrofolate reductase gene variants C677T and A1298C on the risk of orofacial clefts in 261 Norwegian case-parent triads

American Journal of Epidemiology

Volumn 157, Issue 12, 2003, Pages 1083-1091

  Jugessur, Astanand ^a,b   Wilcox, Allen J ^c   Lie, Rolv T ^b   Murray, Jeffrey C ^d   Taylor, Jack A ^c   Ulvik, Arve ^b   Drevon, Christian A ^e   Vindenes, Hallvard A ^a   Åbyholm, Frank E ^f  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF OSLO   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Abnormalities; Cleft lip; Cleft palate; Folic acid; Genes; Genetic predisposition to disease; Haplotypes; Vitamins

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

GENETIC VARIATION; HEALTH RISK; VITAMIN;

ADULT; ALLELE; ARTICLE; CLEFT LIP; CLEFT PALATE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENOME; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PROGENY; RISK FACTOR; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ALANINE; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; CYSTEINE; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NORWAY; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; REGISTRIES; RISK FACTORS; THREONINE; VARIATION (GENETICS);

NORWAY;

EID: 0038315197     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg097     Document Type: Article

References (52)

1. Fogh-Andersen P. Inheritance of harelip and cleft palate. Copenhagen, Denmark: Munksgaard, 1942.
2. Christensen K, Fogh-Andersen P. Etiological subgroups in nonsyndromic isolated cleft palate: a genetic-epidemiological study of 52 Danish birth cohorts. Clin Genet 1994;46:329-35.
3. Lie RT, Wilcox AJ, Skjaerven R. A population-based study of the risk of recurrence of birth defects. N Engl J Med 1994;331: 1-4.
4. Skjaerven R, Wilcox AJ, Lie RT. A population-based study of survival and childbearing among female subjects with birth defects and the risk of recurrence in their children. N Engl J Med 1999;340:1057-62.
5. Lie RT, Wilcox AJ, Skjaerven R. Survival and reproduction among males with birth defects and risk of recurrence in their children. JAMA 2001;285:755-60.
6. Vanderas AP. Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. Cleft Palate J 1987;24:216-25.
7. Croen LA, Shaw GM, Wasserman CR, et al. Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983-1992. Am J Med Genet 1998;79:42-7.
8. Abyholm FE. Cleft lip and palate in Norway. I. Registration, incidence and early mortality of infants with CLP. Scand J Plast Reconstr Surg 1978;12:29-34.
9. Hartridge T, Illing HM, Sandy JR. The role of folic acid in oral clefting. Br J Orthod 1999;26:115-20.
10. Prescott NJ, Malcolm S. Folate and the face: evaluating the evidence for the influence of folate genes on craniofacial development. Cleft Palate Craniofac J 2002;39:327-31.
11. Dansky LV, Andermann E, Rosenblatt D, et al. Anticonvulsants, folate levels, and pregnancy outcome: a prospective study. Ann Neurol 1987;21:176-82.
12. Goyette P, Pai A, Milos R, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 1998;9:652-6.
13. Goyette P, Sumner JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7:195-200.
14. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-13.
15. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-72.
16. van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51.
17. Rosenberg N, Murata M, Ikeda Y, et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in Whites, Japanese, and Africans. Am J Hum Genet 2002;70:758-62.
18. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000;67:986-90.
19. Zetterberg H, Regland B, Palmer M, et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 2002;10:113-18.
20. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143-9.
21. Ulvik A, Ueland PM. Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism. Clin Chem 2001;47:2050-3.
22. Wilcox AJ, Weinberg CR, Lie RT. Distinguishing the effects of maternal and offspring genes through studies of "case-parent triads." Am J Epidemiol 1998;148:893-901.
23. Weinberg CR, Wilcox AJ. Re: "Distinguishing the effects of maternal and offspring genes through studies of 'case-parent triads"' and "a new method for estimating the risk ratio in studies using case-parental control design." (Letter). Am J Epidemiol 1999;150:428-9.
24. Weinberg CR, Wilcox AJ, Lie RT. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 1998;62:969-78.
25. Clayton D, Jones H. Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet 1999;65:11619.
26. Umbach DM, Weinberg CR. The use of case-parent triads to study joint effects of genotype and exposure. Am J Hum Genet 2000;66:251-61.
27. Jugessur A, Lie RT, Wilcox AJ, et al. Variants of developmental genes (TGFA, TGFB3, and MSX1) and their associations with orofacial clefts - a case-parent triad analysis. Genet Epidemiol 2003;24:230-9.
28. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338:131-7.
29. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
30. Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet 1994;255: 131-9.
31. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341:1485-90. (Erratum published in N Engl J Med 1999;341: 1864).
32. Kirke PN, Daly LE, Elwood JH. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child 1992;67:1442-6.
33. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.
34. Whitehead AS, Gallagher P, Mills JL, et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 1995;88:763-6.
35. Tolarova M. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. (Letter). Lancet 1982;2:217.
36. Shaw GM, Lammer EJ, Wasserman CR, et al. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995;346:393-6.
37. Tolarova M, Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 1995;51:71-8.
38. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996;53:345-51.
39. Czeizel AE, Timar L, Sarkozi A. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics 1999;104: e66.
40. Werler MM, Hayes C, Louik C, et al. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 1999;150:67582.
41. Hayes C, Werler MM, Willett WC, et al. Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol 1996;143:1229-34.
42. Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-14.
43. Evans HM, Nelson MM, Asling CW. Multiple congenital abnormalities resulting from acute folic acid deficiency during gestation. Science 1951;114:479.
44. Jordan RL, Wilson JG, Schumacher HJ. Embryotoxicity of the folate antagonist methotrexate in rats and rabbits. Teratology 1977;15:73-9.
45. Kalter H. Folic acid and human malformations: a summary and evaluation. Reprod Toxicol 2000;14:463-76.
46. Feinleib M, Beresford SA, Bowman BA, et al. Folate fortification for the prevention of birth defects: case study. Am J Epidemiol 2001;154:S60-9.
47. Itikala PR, Watkins ML, Mulinare J, et al. Maternal multivitamin use and orofacial clefts in offspring. Teratology 2001;63:79-86.
48. Mills JL, Kirke PN, Molloy AM, et al. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 1999;86:71-4.
49. Shaw GM, Todoroff K, Finnell RH, et al. Maternal vitamin use, infant C677T mutation in MTHFR, and isolated cleft palate risk. Am J Med Genet 1999;85:84-5.
50. Beaty TH, Hetmanski JB, Zeiger JS, et al. Testing candidate genes for non-syndromic oral clefts using a case-parent trio design. Genet Epidemiol 2002;22:1-11.
51. Weinberg CR, Umbach DM. Choosing a retrospective design to assess joint genetic and environmental contributions to risk. Am J Epidemiol 2000;152:197-203.
52. Shaw GM, Rozen R, Finnell RH, et al. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 1998; 148:30-7.